Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13168683 | 0.79 | — | — | |
| SCHEMBL7928389 | 0.74 | — | — | |
| SCHEMBL16588497 | 0.74 | — | — | |
| SCHEMBL18371404 | 0.74 | — | — | |
| SCHEMBL17531779 | 0.74 | — | — | |
| SCHEMBL25143561 | 0.74 | — | — | |
| SCHEMBL18892217 | 0.70 | — | — | |
| SCHEMBL10057888 | 0.70 | — | — | |
| SCHEMBL14043180 | 0.69 | — | — | |
| SCHEMBL14291990 | 0.67 | TRPA1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2002527555-A | — | — | 2002-08-27 | — | — | JP | claimed |
| EP-1121386-A1 | HIGHLY BRANCHED OLIGOMERS, PROCESS FOR THEIR PREPARATION AND APPLICATIONS THEREOF | Epox Ltd. (IL) | 2001-08-08 | — | — | EP | claimed |
| WO-2000022030-A1 | HIGHLY BRANCHED OLIGOMERS, PROCESS FOR THEIR PREPARATION AND APPLICATIONS THEREOF | EPOX LTD. (IL) | 2000-04-20 | — | — | WO | claimed |
| US-20100247439-A1 | DENDRITIC NANO-ANTIOXIDANTS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2010-09-30 | — | — | US | disclosed |
| WO-2007117500-A2 | PROCESSES FOR CHEMICAL SYNTHESIS OF LIPOCHITOOLIGOSACCHARIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-10-18 | — | — | WO | disclosed |
| WO-2007001283-A2 | CHEMICAL SYNTHESIS OF LOW MOLECULAR WEIGHT POLYGLUCOSAMINES AND POLYGALACTOSAMINES | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2007-01-04 | — | — | WO | disclosed |
| WO-2007001282-A2 | LOW MOLECULAR WEIGHT POLYGLUCOSAMINES AND POLYGALACTOSAMINES | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2007-01-04 | — | — | WO | disclosed |
| EP-1121386-A1 | HIGHLY BRANCHED OLIGOMERS, PROCESS FOR THEIR PREPARATION AND APPLICATIONS THEREOF | Epox Ltd. (IL) | 2001-08-08 | — | — | EP | disclosed |
| WO-2000022030-A1 | HIGHLY BRANCHED OLIGOMERS, PROCESS FOR THEIR PREPARATION AND APPLICATIONS THEREOF | EPOX LTD. (IL) | 2000-04-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100247439-A1 | DENDRITIC NANO-ANTIOXIDANTS | GPX1, GPX4, LPO | ALDH1A1 235/4885CA1 3330/4885CA9 4002/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.